Managed Care Cast

Every week, The American Journal of Managed Care® (AJMC®) recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast. This week, the top managed care news included the 2020 budget plan proposing a mix of healthcare spending cuts and increases; the FDA approving the first immunotherapy regimen for breast cancer; and researchers uncovering how sodium glucose co-transporter-2 inhibitors work. Read more about the stories in this podcast: Proposed 2020 White House Budget Includes Block Grants, Medicaid Work Rules, Increased HIV Funding: https://www.ajmc.com/focus-of-the-week/proposed-2020-white-house-budget-includes-block-grants-medicaid-work-rules-increased-hiv-funding FDA Approves Atezolizumab Combination for Triple-Negative Breast Cancer: https://www.ajmc.com/newsroom/fda-approves-atezolizumab-combination-for-triplenegative-breast-cancer SGLT2 Inhibitors Work by Inducing Fasting State, Joslin Center Scientist Says: https://www.ajmc.com/newsroom/sglt2-inhibitor